European Parliament - SANT Subcommittee (Public Health) · July 16, 2026

European Biotech Act: amendments 2522–2801 to draft framework for biotechnology and biomanufacturing sectors

Original title: AMENDMENTS 2522 - 2801 - Draft report Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) - PE790.939v01-00

Parliamentary amendments to proposed EU framework strengthening biotechnology and biomanufacturing, amending regulations on food safety, advanced therapies, clinical trials, veterinary medicines, and medical devices.

Medium impact Medical Devices Pharmaceuticals General Regulatory EU-wide classificationclinical-trialspharmacovigilancemarket-surveillance

AMENDMENTS 2522 - 2801 - Draft report Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)<br />Committee on Industry, Research and Energy<br />Committee on Public Health<br />Wouter Beke, Vytenis Povilas Andriukaitis<br /> <br />Source : <a href="https://www.europarl.europa.eu/privacy-policy/en">© European Union, 2026 - EP</a>

Read the official source ↗

Published by European Parliament - SANT Subcommittee (Public Health). HealthSignal links to the original document; the summary above is extracted from the source text.